Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03605368 · ClinicalTrials.gov registry record · NA

VR Intervention to Improve Police Safety

A NA study, sponsored by Children's Hospital of Philadelphia.

Completed
Registry status
NA
Development phase
158
Enrollment target

NCT03605368: Completed NA study, sponsored by Children's Hospital of Philadelphia.

NCT03605368 is a NA study that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 158 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03605368, a NA study, has completed, sponsored by Children's Hospital of Philadelphia.

COMPLETED
Registry status
NA
Development phase
158 participants
Enrollment target

Study Summary

The primary objective of this study is to demonstrate the efficacy of Floreo's police safety module (PSM) in adolescents and adults with autism spectrum disorder (ASD) by assessing improvement in police interaction skills as compared to a video modeling intervention.

Primary Outcome

The primary efficacy endpoint is the change in live in-person (Phase IIA) or virtual (Phase IIB) Police Interaction Assessment Scores between the Floreo PSM Virtual Reality Intervention and BE SAFE Video-Based intervention (Phase IIA) or treatment-as-usual (Phase IIB) from pre-treatment to post-treatment. Greater pre-treatment to post-treatment scores indicate better 3rd party ratings of social skills in that domain. The range of possible scores for the Police Interaction Assessment is -3 (perfo

Interventions

  • BEHAVIORAL No intervention
  • BEHAVIORAL Virtual Reality Intervention
  • BEHAVIORAL Video Modeling Intervention

Trial Details

FieldValue
Enrollment Target 158 participants
Start Date 2017-11-17
Est. Completion 2022-10-12
Phase NA
Children's Hospital of Philadelphia

431 total trials

What the finished NCT03605368 record still lists

NCT03605368 is an interventional study that assigns participants to a tested intervention. The registered 158 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).

The record links to 0 conditions, and to 3 interventions - of which No intervention is the first listed.

NCT03605368 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03605368 about?

NCT03605368 is a clinical study titled "VR Intervention to Improve Police Safety". The primary objective of this study is to demonstrate the efficacy of Floreo's police safety module (PSM) in adolescents and adults with autism spectrum disorder (ASD) by assessing improvement in police interaction skills as compared to a video modeling intervention.

What is the current status of trial NCT03605368?

This trial is currently completed. It is a NA study. The enrollment target is 158 participants. The study started on 2017-11-17. Estimated completion is 2022-10-12.

What interventions are being tested in trial NCT03605368?

The interventions under investigation include: No intervention (BEHAVIORAL), Virtual Reality Intervention (BEHAVIORAL), Video Modeling Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT03605368?

This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03605368's enrollment target sits among peer trials

158 654th of 2000 higher than 1,345 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04486833 · 158 participants · Phase 1

    Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib

  • NCT04697966 · 158 participants · NA

    Mechanisms and Predictors of Change in App-Based Mindfulness Training for Adolescents

  • NCT04969835 · 158 participants · Phase 1

    A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours

  • NCT05230732 · 158 participants · NA

    Neuromodulation of Inflammation and Endothelial Function

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03605368, the US trial registry maintained by the National Library of Medicine. NCT03605368 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.